ophthalmology

Marketing

Ocular Therapeutix sharpens focus with retina-centric rebrand

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli.

Nick Paul Taylor Jun 27, 2025 10:05am

Earnings chart

Apellis' weak quarter could signal Syfovre 'nadir': analysts

Nov 5, 2024 3:41pm

eye close-up eye retina retinal ophthalmology eye exam

EyePoint's Duravyu bounces back with promising DME data

Oct 28, 2024 1:11pm

lawsuits litigation patent litigation intellectual property

Amgen gears up to launch Eylea biosim as Regeneron plots appeal

Oct 23, 2024 10:16am

Astellas Pharma Izervay campaign

Astellas cruises into first DTC campaign for GA med Izervay

Sep 30, 2024 4:00pm

FDA

EyePoint's Yutiq production lands in the FDA's crosshairs

Aug 27, 2024 4:07pm